The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder

Back to table of contents Previous article Next article APA Official ActionsNo AccessThe American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use DisorderVictor I. Reus, M.D., Laura J. Fochtmann, M.D., M.B.I., Oscar Bukstein, M.D., M.P.H., A. Evan Eyler, M.D., M.P.H., Donald M. Hilty, M.D., Marcela Horvitz-Lennon, M.D., M.P.H., Jane Mahoney, Ph.D., R.N., PMHCNS-B.C., Jagoda Pasic, M.D., Ph.D., Michael Weaver, M.D., Cheryl D. Wills, M.D., Jack McIntyre, M.D. , Jeremy Kidd, M.D. , Joel Yager, M.D. , Seung-Hee Hong Victor I. ReusSearch for more papers by this author, M.D., Laura J. FochtmannSearch for more papers by this author, M.D., M.B.I., Oscar BuksteinSearch for more papers by this author, M.D., M.P.H., A. Evan EylerSearch for more papers by this author, M.D., M.P.H., Donald M. HiltySearch for more papers by this author, M.D., Marcela Horvitz-LennonSearch for more papers by this author, M.D., M.P.H., Jane MahoneySearch for more papers by this author, Ph.D., R.N., PMHCNS-B.C., Jagoda PasicSearch for more papers by this author, M.D., Ph.D., Michael WeaverSearch for more papers by this author, M.D., Cheryl D. WillsSearch for more papers by this author, M.D., Jack McIntyreSearch for more papers by this author, M.D. (Consultant), Jeremy KiddSearch for more papers by this author, M.D. (Consultant), Joel YagerSearch for more papers by this author, M.D. (Systematic Review), Seung-Hee HongSearch for more papers by this author (Systematic Review)Published Online:5 Jan 2018https://doi.org/10.1176/appi.ajp.2017.1750101AboutSectionsView articleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinked InEmail View article Access content To read the fulltext, please use one of the options below to sign in or purchase access. Personal login Institutional Login Sign in via OpenAthens Purchase Save for later Item saved, go to cart PPV Articles - American Journal of Psychiatry $35.00 Add to cart PPV Articles - American Journal of Psychiatry Checkout Please login/register if you wish to pair your device and check access availability. Not a subscriber? Subscribe Now / Learn More PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development. Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.). FiguresReferencesCited byDetailsCited byWhich interventions for alcohol use should be included in a universal healthcare benefit package? An umbrella review of targeted interventions to address harmful drinking and dependence23 February 2023 | BMC Public Health, Vol. 23, No. 1Time to Treat Alcohol Use Disorder in the Emergency DepartmentAnnals of Emergency Medicine, Vol. 81, No. 4Psychobiotic interventions attenuate chronic alcohol use-mediated exacerbation of posttraumatic stress disorder in rats: the role of gut-liver axis response21 December 2022 | Journal of Complementary and Integrative Medicine, Vol. 20, No. 1Disulfiram: Mechanisms, Applications, and Challenges6 March 2023 | Antibiotics, Vol. 12, No. 3Combined pharmacological and psychosocial interventions for alcohol use disorder8 March 2023 | Cochrane Database of Systematic Reviews, Vol. 2023, No. 3Alcohol use disorder in community management of chronic liver diseases17 February 2023 | Hepatology, Vol. 77, No. 3The impact of COVID‐19 on trends in alcohol use disorder treatment in Veterans Health Administration28 February 2023 | Addiction, Vol. 230Substance use and related disorders among persons exposed to the 9/11 terrorist attacks: Essentials for screening and intervention27 February 2023 | Archives of Environmental & Occupational HealthThe use of medications approved for alcohol use disorders in Italy15 February 2023 | Frontiers in Public Health, Vol. 11Alcoholic HepatitisMedical Clinics of North America, Vol. 150Therapeutic Pipeline in Alcohol-Associated Liver Disease26 December 2022 | Seminars in Liver Disease, Vol. 43, No. 01Alcohol-Associated Liver Disease: Integrated Management With Alcohol Use DisorderClinical Gastroenterology and Hepatology, Vol. 387An intensive longitudinal examination of topiramate treatment for alcohol use disorder: a secondary analysis of data from a randomized controlled trial25 January 2023 | Addiction, Vol. 39Understanding Ohio X-Waivered Advanced Practice Registered Nurses’ Rate of Naltrexone Prescription for Alcohol Use Disordered Patients24 January 2023 | Journal of the American Psychiatric Nurses Association, Vol. 63Revised Clinical Practice Guidelines of the Korean Pancreatobiliary Association for Acute Pancreatitis17 August 2022 | Gut and Liver, Vol. 17, No. 1Relationship Between Primary Care Providers’ Perceptions of Alcohol Use Disorder And Pharmacotherapy Prescribing Rates11 November 2022 | Alcohol and Alcoholism, Vol. 58, No. 1Alcohol Use DisorderDrugs Used in Withdrawal Management and Post-Withdrawal Management1 February 2023Types of addictionA cohort study examining changes in treatment patterns for alcohol use disorder among commercially insured adults in the United States during the COVID-19 pandemicJournal of Substance Abuse Treatment, Vol. 144Understanding motivations and use typologies of gabapentin with opioid agonist medicationsDrug and Alcohol Dependence, Vol. 242Baclofen for alcohol use disorder13 January 2023 | Cochrane Database of Systematic Reviews, Vol. 2023, No. 1Hazardous drinking and alcohol use disorders22 December 2022 | Nature Reviews Disease Primers, Vol. 8, No. 1Barriers and facilitators to changing drinking and receiving alcohol-related care: Interviews with Veterans Health Administration primary care patients who indicated interest but did not enroll in an alcohol care management intervention trial3 June 2022 | Substance Abuse, Vol. 43, No. 1Improving the utilisation of medication-assisted treatment for alcohol use disorder at discharge12 December 2022 | BMJ Open Quality, Vol. 11, No. 4Eosinophilic pustular folliculitis due to naltrexone: A case reportJournal of the American Pharmacists Association, Vol. 62, No. 6Drugs for Treating Alcohol Use Disorder During LactationBreastfeeding Medicine, Vol. 17, No. 11Pharmacotherapies for Adults With Alcohol Use Disorders: A Systematic Review and Network Meta-analysisJournal of Addiction Medicine, Vol. 16, No. 6Alcohol UseAnnals of Internal Medicine, Vol. 175, No. 10Alcohol Drinking, Smoking, and DiabetesThe Journal of Korean Diabetes, Vol. 23, No. 3Stigmatizing Terminology for Outcomes and Processes (STOP) in Alcohol Research: A Meta-epidemiologic Assessment of Language Used in Clinical Trial Publications22 April 2022 | Journal of Addiction Medicine, Vol. 16, No. 5Perspectives on the pharmacological management of alcohol use disorder: Are the approved medications effective?European Journal of Internal Medicine, Vol. 103Knowledge atlas of the involvement of glutamate and GABA in alcohol use disorder: A bibliometric and scientometric analysis12 August 2022 | Frontiers in Psychiatry, Vol. 13Early treatment with thiamine and mortality among patients with alcohol use disorder who are hospitalized for pneumonia21 June 2022 | Journal of Hospital Medicine, Vol. 17, No. 8Review article: current and emerging therapies for acute alcohol‐associated hepatitis14 May 2022 | Alimentary Pharmacology & Therapeutics, Vol. 56, No. 1Effects of Alcohol Withdrawal on Sleep Macroarchitecture and Microarchitecture in Female and Male Rats10 June 2022 | Frontiers in Neuroscience, Vol. 16Psychosocial and medication interventions to stop or reduce alcohol consumption during pregnancy27 April 2022 | Cochrane Database of Systematic Reviews, Vol. 2022, No. 6Medication prescribing for alcohol use disorders during alcohol‐related encounters in a Colorado regional healthcare system20 June 2022 | Alcoholism: Clinical and Experimental Research, Vol. 46, No. 6The Need for Integrating Addiction Medicine and Hepatology20 May 2022 | JAMA Network Open, Vol. 5, No. 5Treating Alcohol Use Disorder in Patients with Alcohol-Associated Liver Disease: Controversies in Pharmacological Therapy23 June 2022 | Seminars in Liver Disease, Vol. 42, No. 02Brain Correlates of the Alcohol Use Disorder Pharmacotherapy Response: A Systematic Review of Neuroimaging Studies14 March 2022 | Brain Sciences, Vol. 12, No. 3Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder8 February 2022 | Drugs, Vol. 82, No. 3Treatment of alcohol use disorder in patients with liver diseaseCurrent Opinion in Pharmacology, Vol. 62Alcohol Use Disorder in Older AdultsClinics in Geriatric Medicine, Vol. 38, No. 1Recommendations from Current German, British, American, and Australian Guidelines on Alcohol Treatment5 November 2022Substance Use and Substance Use Disorders6 October 2022Online 12-step groups during the Covid-19 pandemic: A patient's perspectiveEmerging Trends in Drugs, Addictions, and Health, Vol. 2Management of alcohol use disorder in patients with cirrhosis in the setting of liver transplantation1 November 2021 | Nature Reviews Gastroenterology & Hepatology, Vol. 19, No. 1Pharmacological interventions for alcohol misuse in correctional settings: A systematic review8 December 2021 | Alcoholism: Clinical and Experimental Research, Vol. 46, No. 1Revised Clinical Practice Guideline of Korean Pancreatobiliary Association for Acute Pancreatitis: Initial Treatment, Nutritional Support, Convalescent Treatment31 January 2022 | The Korean Journal of Pancreas and Biliary Tract, Vol. 27, No. 1Short-term naltrexone use associated with delayed-onset fever and hepatotoxicity: A case reportTaiwanese Journal of Psychiatry, Vol. 36, No. 4The Spectrum of Alcohol UseMedical Clinics of North America, Vol. 106, No. 1New Access Routes to Undertreated Populations; How Do Problem Substance Users Recruited from an Unemployment Office Differ from Detoxification Treatment Inpatients?9 December 2021 | International Journal of Environmental Research and Public Health, Vol. 18, No. 24Treatment for alcohol use disorder among persons with and without HIV in a clinical care setting in the United StatesDrug and Alcohol Dependence, Vol. 229Impact of a pharmacist-led substance use disorder transitions of care clinic on postdischarge medication treatment retentionJournal of Substance Abuse Treatment, Vol. 130Alcohol Reduction to Reduce Relapse in Acute Alcoholic Pancreatitis—Missed Opportunities26 March 2021 | Alcohol and Alcoholism, Vol. 56, No. 6Pharmacotherapy for alcohol use disorders – Unequal provision across sociodemographic factors and co-morbid conditions. A cohort study of the total population in SwedenDrug and Alcohol Dependence, Vol. 227Exploring the Role of Alcohol Metabolizing Genotypes in a 12-Week Clinical Trial of Naltrexone for Alcohol Use Disorder10 October 2021 | Biomolecules, Vol. 11, No. 10Use of Medications for Alcohol Use Disorder in the USJAMA Psychiatry, Vol. 78, No. 8Implementation of Oral and Extended-Release Naltrexone for the Treatment of Emergency Department Patients With Moderate to Severe Alcohol Use Disorder: Feasibility and Initial OutcomesAnnals of Emergency Medicine, Vol. 320Approaching Alcohol Use Disorder After Liver Transplantation for Acute Alcoholic HepatitisClinics in Liver Disease, Vol. 25, No. 3Trends in the Use of Naltrexone for Addiction Treatment among Alcohol Use Disorder Admissions in U.S. Substance Use Treatment Facilities23 August 2021 | International Journal of Environmental Research and Public Health, Vol. 18, No. 16Characterizing the Variation of Alcohol Cessation Pharmacotherapy in Primary Care29 January 2021 | Journal of General Internal Medicine, Vol. 36, No. 7Use of Medications for the Treatment of Alcohol Dependence: A Retrospective Study Conducted in 2011-2012Current Drug Research Reviews, Vol. 13, No. 2Mental health management of elite athletes during COVID-19: a narrative review and recommendations23 September 2020 | British Journal of Sports Medicine, Vol. 55, No. 11Pharmacotherapies for the Treatment of Alcohol Use Disorders During Pregnancy: Time to Reconsider?8 April 2021 | Drugs, Vol. 81, No. 7Consistency between self-reported alcohol consumption and biological markers among patients with alcohol use disorder – A systematic reviewNeuroscience & Biobehavioral Reviews, Vol. 124Alcohol Use Disorder and Hepatitis C Prevention and Care in People Who Inject Drugs: The State of Play26 August 2020 | Seminars in Liver Disease, Vol. 41, No. 02Veteran adherence to oral versus injectable AUD medication treatment12 May 2021 | Mental Health Clinician, Vol. 11, No. 3Naltrexone Initiation in the Inpatient Setting for Alcohol Use Disorder: A Systematic Review of Clinical OutcomesMayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol. 5, No. 2Carnitine in Alcohol Use Disorders: A Scoping Review7 March 2021 | Alcoholism: Clinical and Experimental Research, Vol. 45, No. 4The effects of binge drinking on healthy and diseased liversCanadian Liver Journal, Vol. 4, No. 2Gabapentin dependence and withdrawal requiring an 18-month taper in a patient with alcohol use disorder: a case report30 March 2021 | Journal of Addictive DiseasesDrug Repurposing of the Alcohol Abuse Medication Disulfiram as an Anti-Parasitic Agent11 March 2021 | Frontiers in Cellular and Infection Microbiology, Vol. 11The future of translational research on alcohol use disorder14 April 2020 | Addiction Biology, Vol. 26, No. 2A Novel Dual Drug Approach That Combines Ivermectin and Dihydromyricetin (DHM) to Reduce Alcohol Drinking and Preference in Mice22 March 2021 | Molecules, Vol. 26, No. 6Alcohol Use Disorder in a Culture That Normalizes the Consumption of Alcoholic Beverages: The Conflicts for Decision-Making12 December 2020Substance Use Disorder and HIV22 August 2020Opioid Analegiscs and Drugs for Alcohol Use Disorder22 December 2020Recommendations from Current German, British, American, and Australian Guidelines on Alcohol Treatment10 June 2021Identifying and Managing Eating Disorders in Persons Presenting for Addiction Treatment1 December 2021 | Canadian Journal of Addiction, Vol. 12, No. 4Is naltrexone an effective treatment for adults with alcohol use disorder?1 July 2021 | Evidence-Based Practice, Vol. 24, No. 7What can primary care services do to help First Nations people with unhealthy alcohol use? A systematic review: Australia, New Zealand, USA and Canada18 August 2020 | Addiction Science & Clinical Practice, Vol. 15, No. 1Mifepristone Decreases Chronic Voluntary Ethanol Consumption in Rhesus Macaques1 September 2020 | Journal of Pharmacology and Experimental Therapeutics, Vol. 375, No. 2Management of Sedation and Analgesia in Critically Ill Patients Receiving Long-Acting Naltrexone Therapy for Opioid Use DisorderAnnals of the American Thoracic Society, Vol. 17, No. 11Correlates of alcohol use disorder pharmacotherapy receipt in medically insured patientsDrug and Alcohol Dependence, Vol. 214Evidence-Based Pharmacotherapies for Alcohol Use DisorderMayo Clinic Proceedings, Vol. 95, No. 9Inpatient adoption of medications for alcohol use disorder: A mixed-methods formative evaluation involving key stakeholdersDrug and Alcohol Dependence, Vol. 213Long‐term safety and efficacy of nalmefene in Japanese patients with alcohol dependence27 May 2020 | Psychiatry and Clinical Neurosciences, Vol. 74, No. 8Chapter 30: Toxicology29 July 2020Understanding the neurobiological effects of drug abuse: Lessons from zebrafish modelsProgress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 100Impact of Alcohol Use Disorder Treatment on Clinical Outcomes Among Patients With Cirrhosis22 May 2020 | Hepatology, Vol. 71, No. 6Lifestyle and Risk Factor Modification for Reduction of Atrial Fibrillation: A Scientific Statement From the American Heart AssociationCirculation, Vol. 141, No. 16Survey of Addiction Specialists’ Use of Medications to Treat Alcohol Use Disorder14 February 2020 | Frontiers in Psychiatry, Vol. 11Ketamine Plus Motivational Enhancement Therapy: Leveraging a Rapid Effect to Promote Enduring ChangeSanjay J. Mathew, M.D., Rebecca B. Price, Ph.D.1 February 2020 | American Journal of Psychiatry, Vol. 177, No. 2Predictors of initiation of and retention on medications for alcohol use disorder among people living with and without HIVJournal of Substance Abuse Treatment, Vol. 109Safety of nalmefene for the treatment of alcohol use disorder: an update30 December 2019 | Expert Opinion on Drug Safety, Vol. 19, No. 1Alcohols: volatiles and glycolsBrain activation and subjective anxiety during an anticipatory anxiety task is related to clinical outcome during prazosin treatment for alcohol use disorderNeuroImage: Clinical, Vol. 26Influence of combined treatment with naltrexone and memantine on alcohol drinking behaviors: a phase II randomized crossover trial7 October 2019 | Neuropsychopharmacology, Vol. 45, No. 2Diagnosis and Treatment of Alcohol Use Disorder in Patients With End‐Stage Alcoholic Liver Disease17 January 2019 | Hepatology, Vol. 70, No. 1Efficacy of Pharmacological Interventions in Targeting Decision-Making Impairments across Substance and Behavioral Addictions9 March 2019 | Neuropsychology Review, Vol. 29, No. 1Prevalence of and pathways to benzodiazepine use in Brazil: the role of depression, sleep, and sedentary lifestyle1 February 2019 | Brazilian Journal of Psychiatry, Vol. 41, No. 1WFSBP and IAWMH Guidelines for the treatment of alcohol use disorders in pregnant women11 January 2019 | The World Journal of Biological Psychiatry, Vol. 20, No. 1Use of Disulfiram for Treatment of Alcohol Addiction in Patients With Psychotic IllnessJoseph Benjamin Williams, M.D.1 January 2019 | American Journal of Psychiatry, Vol. 176, No. 1Internal and Emergency Medicine, Vol. 14, No. 1Journal of Behavior Therapy and Experimental Psychiatry, Vol. 64Addiction, Vol. 114, No. 9PLOS ONE, Vol. 14, No. 4Treatment management of psychoactive substance use disordersPsihiatru.ro, Vol. 4, No. 59Frontiers in Psychiatry, Vol. 9Frontiers in Psychiatry, Vol. 10Alcohol Withdrawal Management and Relapse Prevention in PregnancyCanadian Journal of Addiction, Vol. 9, No. 4Microscopes and Telescopes: the Societal Impact of Substance Use Disorder TreatmentHilary S. Connery, M.D., Ph.D., Roger D. Weiss, M.D.1 October 2018 | American Journal of Psychiatry, Vol. 175, No. 10Response to: “Drugs for treatment for alcohol use disorders expose to interactions with others … for little benefit if any”Pharmacological Research, Vol. 134JAMA, Vol. 320, No. 8Neuropsychopharmacology Reports, Vol. 38, No. 3The Lancet Psychiatry, Vol. 5, No. 12Addictive Behaviors Reports, Vol. 8European Journal of Pharmacology, Vol. 836Substance Abuse, Vol. 39, No. 2Frontiers in Psychiatry, Vol. 9Alcohol Use Disorder9 February 2017 Volume 175Issue 1 January 01, 2018Pages 86-90 Metrics PDF download History Published online 5 January 2018 Published in print 1 January 2018